rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Glivec

Rediff.com  »  News  »   Glivec

  News for Glivec

  • Business

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court  judgement (pages 22 -26) quite extensively quoted from Sudip......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

'Novartis ruling won't affect pharma industry'

Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board, has recently ruled that the......

'US industry reviewing SC decision on Novartis'

The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......

The man behind Glivec hails verdict against Novartis

Even though Novartis and other multinational corporations are upset with the Indian Supreme Court’s decision to reject Novartis’ patent claim on Glivec, the key man behind the popular......
  Web results for Glivec
Novartis delivered solid performance in the second quarter, with strong innovation and progress on new launches

Comments July 21, 2015 - London Novartis International AG /Novartis delivered solid performance in the second quarter, with strong innovation and... ...

http://andhranews.net/Business/2015/Novartis-delivered-solid-performance-second-quarter-28238.htm
Sun

I The company says FY16 revenues will be flat, with a slightly negative bias, compared to the last fiscal. It has also said that consolidated... ...

http://www.moneycontrol.com/news/cnbc-tv18-comments/ranbaxy-integration-impact-to-be-controlledfy17-sun_2059981.html
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2015

--(PR.com)-- DelveInsight, the leading market research and consulting company has added new report, " " to its portfolio. With this launch... ...

http://www.bizwireexpress.com/showstoryPRcom.php?storyid=379705
Compulsory license application may prove to be test for Modi govt

Mumbai: After a gap of about two years, the filing of a compulsory license (CL) application against a patented drug owned by a multinational... ...

http://www.livemint.com/Companies/zY6RfSCfgBo7EOiHXMVkOO/Compulsory-license-application-may-prove-to-be-test-for-Modi.html
Delhi HC upholds BMS’ patent for cancer drug Dasatinib

MUMBAI: The Delhi High Court has upheld the patent of US-based Bristol Myers Squibs (BMS) for Dasatinib, dashing the hopes of a local company to... ...

http://economictimes.feedsportal.com/c/33041/f/534022/s/47dae0e2/sc/7/l/0Leconomictimes0Bindiatimes0N0Cindustry0Chealthcare0Cbiotech0Cpharmaceuticals0Cdelhi0Ehigh0Ecourt0Eupholds0Ebms0Epatent0Efor0Ecancer0Edrug0Edasatinib0Carticleshow0C479525590Bcms/story01.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z